These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 6841534

  • 21. High-performance liquid chromatographic assay of diltiazem and six of its metabolites in plasma: application to a pharmacokinetic study in healthy volunteers.
    Yeung PK, Montague TJ, Tsui B, McGregor C.
    J Pharm Sci; 1989 Jul; 78(7):592-7. PubMed ID: 2778663
    [Abstract] [Full Text] [Related]

  • 22. Simultaneous determination of diltiazem and quinidine in human plasma by liquid chromatography.
    Carignan G, Carrier K, Laganière S, Lessard M.
    J Chromatogr B Biomed Appl; 1995 Oct 20; 672(2):261-9. PubMed ID: 8581132
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics of the calcium-channel blocker diltiazem after a single intravenous dose in horses.
    Schwarzwald CC, Sams RA, Bonagura JD.
    J Vet Pharmacol Ther; 2006 Jun 20; 29(3):165-71. PubMed ID: 16669860
    [Abstract] [Full Text] [Related]

  • 24. Quantitation of diltiazem in human cardiac tissue using high-performance liquid chromatography.
    Läer S, Scholz H, Uebeler P, Neumann J, Zimmermann N.
    J Chromatogr Sci; 1997 Mar 20; 35(3):93-6. PubMed ID: 9062986
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetics of diltiazem and its metabolites after repeated single dosing in healthy volunteers.
    Höglund P, Nilsson LG.
    Ther Drug Monit; 1989 Sep 20; 11(5):551-7. PubMed ID: 2815230
    [Abstract] [Full Text] [Related]

  • 26. Simple, sensitive and rapid liquid chromatographic/electrospray ionization tandem mass spectrometric method for the quantification of lacidipine in human plasma.
    Ramakrishna NV, Vishwottam KN, Puran S, Manoj S, Santosh M, Koteshwara M.
    J Mass Spectrom; 2004 Jul 20; 39(7):824-32. PubMed ID: 15282762
    [Abstract] [Full Text] [Related]

  • 27. Determination of diltiazem in human whole blood and plasma by high-performance liquid chromatography using a polymeric reversed-phase column and utilizing a salting-out extraction procedure.
    Rustum AM.
    J Chromatogr; 1989 May 30; 490(2):365-75. PubMed ID: 2768409
    [Abstract] [Full Text] [Related]

  • 28. Simultaneous determination of a new dihydropyridine calcium antagonist (MPC-1304) and its metabolite in dog plasma by high-performance liquid chromatography with electrochemical detection.
    Iida Y, Kinouchi Y, Takeichi Y, Imai T, Otagiri M.
    J Chromatogr; 1991 Nov 15; 571(1-2):277-82. PubMed ID: 1810957
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetic and pharmacodynamic effects of diltiazem.
    Smith MS, Verghese CP, Shand DG, Pritchett EL.
    Am J Cardiol; 1983 May 01; 51(8):1369-74. PubMed ID: 6846164
    [Abstract] [Full Text] [Related]

  • 30. Determination of a new calcium antagonist, sesamodil fumarate (SD-3211), and its metabolite in plasma by liquid chromatography with electrochemical detection.
    Morishima K, Tahara R, Horiuchi M.
    J Chromatogr; 1990 May 18; 527(2):381-8. PubMed ID: 2387885
    [Abstract] [Full Text] [Related]

  • 31. Steady-state plasma concentrations of diltiazem and its metabolites in patients and healthy volunteers.
    Yeung PK, Buckley SJ, Hung OR, Pollak PT, Barclay KD, Feng JD, Farmer PS, Klassen GA.
    Ther Drug Monit; 1996 Feb 18; 18(1):40-5. PubMed ID: 8848819
    [Abstract] [Full Text] [Related]

  • 32. Analysis of diltiazem in Lipoderm transdermal gel using reversed-phase high-performance liquid chromatography applied to homogenization and stability studies.
    Buur JL, Baynes RE, Yeatts JL, Davidson G, Defrancesco TC.
    J Pharm Biomed Anal; 2005 Jun 01; 38(1):60-5. PubMed ID: 15907620
    [Abstract] [Full Text] [Related]

  • 33. Gender related pharmacokinetics of diltiazem in healthy subjects.
    Sáenz-Campos D, Bayés MC, Martin S, Barbanoj MJ, Jané F.
    Int J Clin Pharmacol Ther; 1995 Jul 01; 33(7):397-400. PubMed ID: 7582396
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Solid-phase extraction of diltiazem and its metabolites from plasma prior to high-performance liquid chromatography.
    Boulieu R, Bonnefous JL, Ferry S.
    J Chromatogr; 1990 Jun 29; 528(2):542-6. PubMed ID: 2384593
    [No Abstract] [Full Text] [Related]

  • 36. Determination of diltiazem hydrochloride enantiomers in dog plasma using chiral stationary-phase liquid chromatography.
    Ishii K, Banno K, Miyamoto T, Kakimoto T.
    J Chromatogr; 1991 Mar 08; 564(1):338-45. PubMed ID: 1860931
    [Abstract] [Full Text] [Related]

  • 37. Determination of diltiazem hydrochloride in human serum by high-performance liquid chromatography.
    Chaudhary RS, Gangwal SS, Avachat MK, Shah YN, Jindal KC.
    J Chromatogr; 1993 May 05; 614(2):261-6. PubMed ID: 8314938
    [Abstract] [Full Text] [Related]

  • 38. Effect of Ca2+ channel blockers on arterial hypertension and heart ischaemic lesions induced by chronic blockade of nitric oxide in the rat.
    de Oliveira CF, Nathan LP, Metze K, Moreno H, de Luca IM, Sucupira M, Zatz R, Zappellini A, Antunes E, de Nucci G.
    Eur J Pharmacol; 1999 Jun 04; 373(2-3):195-200. PubMed ID: 10414439
    [Abstract] [Full Text] [Related]

  • 39. The influence of cimetidine on the pharmacokinetics of diltiazem and its main metabolite in rabbits.
    Choi JS, Burm JP.
    Arch Pharm Res; 2004 Feb 04; 27(2):254-8. PubMed ID: 15022730
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.